Rapilysin Lyophilisat

Country: Շվեյցարիա

language: գերմաներեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

reteplasum

MAH:

Mepha Pharma AG

ATC_code:

B01AD07

INN:

reteplasum

pharmaceutical_form:

Lyophilisat

composition:

Praeparatio cryodesiccata: reteplasum 10 U., acidum tranexamicum, acidum phosphoricum, dikalii phosphas trihydricus, saccharum, polysorbatum 80, pro vitro. Solvens: aqua ad iniectabilia 10 ml.

therapeutic_group:

Biotechnologika

therapeutic_area:

Thrombolytische Therapie bei akutem Herzinfarkt

authorization_date:

1996-12-20